Session Details
 DV9041 - Eradicating Hepatitis B and C
Tuesday, May 21, 2019
09:00 AM - 10:00 AM
$0     CME 
Location: 402
Description:
CME NUMBER: DV9041
The national and international goal is to eradicate hepatitis B and C by the year 2030, but in the U.S. the opioid epidemic and a failure to utilize appropriate prevention and treatment measures have slowed progress towards this end. PAs must be aware of current guidelines and be able to apply them to their patient population in order to best aid in achieving the bast care both for their patients and for the population as a whole. In this session current strategies and guidelines will be reviewed, then participants will participate in a series of cases aimed at solidifying the application of this knowledge in the clinical context.

At the end of this session, participants should be able to:
• Describe current national and international goals to eradicate hepatitis B and C (HBV and HCV) by 2030
• Describe the epidemiology of HBV and HCV infection and transmission in the U.S.
• Discuss ways in which PAs can contribute to achieving HBV and HCV eradication through prevention, testing, and treatment
• Describe specific interventions to detect, prevent, and treat HBV or HCV infection


PHARMACOLOGY
AAPA CONFERENCE ON DEMAND

Speaker(s):
CME Track(s):
Name
INFD - Infectious Disease/HIV
GAST - Gastroenterology
PREV - Preventive Medicine